Kynam Capital Management, LP Krystal Biotech, Inc. Transaction History

Kynam Capital Management, LP

  • $1.28 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$48.93 - $73.47 $899,969 - $1.35 Million
-18,393 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$51.99 - $72.11 $853,831 - $1.18 Million
-16,423 Reduced 47.17%
18,393 $1.22 Million
Q4 2021

Feb 14, 2022
BUY
$39.81 - $88.24 $1.39 Million - $3.07 Million
34,816 New
34,816 $2.44 Million

Others Institutions Holding KRYS

# of Institutions
275
Shares Held
24.9M
Call Options Held
270K
Put Options Held
172K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.53B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email